Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
“Yesterday’s vote in the European Parliament marks an important shift in how Europe prepares for and protects access to critical medicines. The SANT Committee’s decision to refine the scope of the Critical Medicines Act (CMA), by recognising the distinct characteristics of different pharmaceutical supply chains, is a welcome move.
For the CMA to reach its full potential and properly safeguard patients, it needs to account for how medicines are actually developed and manufactured. Plasma-derived medicines, which rely on voluntary donations and complex production processes, demonstrate why tailored policy solutions and regulatory flexibility are essential.
As the trilogues will begin in the new year, I look forward to Council of the European Union and European Commission to align with the EP’s position on this matter.
I also urge policymakers to keep patients at the centre of their thinking during these negotiations. Access and availability of medicines must be prioritised. Unilateral and uncoordinated national stockpiling can have unwanted consequences on PDMP supply, which is why PPTA Europe recommends avoiding national stockpiling and limiting EU-level stockpiling to clearly defined crisis situations.
Read PPTA’s full statement in response to the recent vote.”
Read more about PPTA updates on Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin